Company: PGEN
Filing Date: 2025-03-19
Form Type: 10-K
Source: 0001356090-25-000007
Chunk: 280

Company: PRECIGEN, INC.
Filing Date: 2025-03-19
Form: 10-K
Item: Item 16
Chunk 280
---
,075 Deferred revenue589 509 Current portion of lease liabilities956 1,202 Total current liabilities21,518 22,985 Deferred revenue, net of current portion1,934 1,818 Lease liabilities, net of current portion4,546 5,895 Deferred tax liabilities— 1,847 Warrant liabilities50,537 — Total liabilities78,535 32,545 Commitments and contingencies (Note 15)Mezzanine EquitySeries A  Preferred Stock, no par value, 81,000 shares and zero shares authorized as of December 31, 2024 and December 31, 2023, respectively; 79,000 shares and zero shares issued as of  December 31, 2024 and December 31, 2023, respectively; aggregate liquidation preference of $79,000 as of December 31, 2024.28,218 — Shareholders' equityCommon stock, no par value, 400,000,000 shares authorized as of December 31, 2024 and 2023; 292,869,097 shares and 256,398,527 shares issued as of December 31, 2024 and 2023, 107,130,903 shares and 248,919,096 shares outstanding as of December 31, 2024 and 2023, respectively.— — Additional paid-in capital2,129,207 2,084,916 Accumulated deficit(2,090,706)(1,964,471)Accumulated other comprehensive income (loss)12 (1,947)Total shareholders' equity38,513 118,498 Total liabilities, mezzanine equity and shareholders' equity$145,266 $151,043 

The accompanying notes are an integral part of these consolidated financial statements.

F-6

Precigen, Inc. and Subsidiaries

Consolidated Statements of Operations

Years Ended December 31, 2024, 2023, and 2022 

(Amounts in thousands, except share and per share data)202420232022RevenuesCollaboration and licensing revenues, including $14,561 from related parties in 2022.$— $75 $14,661 Product revenues422 840 1,903 Service revenues3,470 5,301 10,094 Other revenues33 9